bioleaper
Firmenname:
bioleaper
Telefon:
-
E-Mail:
guojing@bioleaper.com
Nationalität:
China
URL:
www.bioleaper.com/
Produkte insgesamt:
5616
48
49
50
51
52
53
54
55
56
57
Produktkatalog
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (geptanolimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (penpulimab)
Anti-PCSK9 Reference Antibody (tafolecimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (dostarlimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sintilimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (zimberelimab)
Anti-PRAME Reference Antibody (Eureka patent anti-PRAME)
Anti-P-Selectin / CD62p Reference Antibody (crizanlizumab)
Anti-ROR1 Reference Antibody (zilovertamab)
Anti-S100A4 Reference Antibody (LK-1)
Anti-Siglec-2 / CD22 Reference Antibody (NCI m971)
Anti-Siglec-3 / CD33 Reference Antibody (vadastuximab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (iparomlimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pidilizumab)
Anti-PDGFRA / CD140a Reference Antibody (tovetumab)
Anti-Phosphorylcholine Reference Antibody (ATH3G10)
Anti-PTPRC / CD45 Reference Antibody (apamistamab)
Anti-RG1 Reference Antibody (19G9)
Anti-SCN11a / Nav1.9 Reference Antibody (Wuhan U. patent anti-Nav1.9)
Anti-Sialyl-Lewis A Reference Antibody (MVT-5873)
Anti-SIRPa Reference Antibody (KWAR23)
Anti-SLC1A5 / ASCT2 Reference Antibody (idactamab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (balstilimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (ezabenlimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab)
Anti-PDGFB Reference Antibody (MOR-8457)
Anti-PRLR / Prolactin Receptor Reference Antibody (BAY 1158061)
Anti-P-Selectin / CD62p Reference Antibody (inclacumab)
Anti-RSPO1 Reference Antibody (Oncomed patent anti-RSPO1)
Anti-SARS Reference Antibody (80R )
Anti-SEMA4D / CD100 Reference Antibody (pepinemab)
Anti-Siglec-4a / MAG Reference Antibody (refanezumab)
Anti-SLAMF7 / CS1 Reference Antibody (azintuxizumAb)
Anti-PCSK9 Reference Antibody (RG7652)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (camrelizumab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sasanlimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (toripalimab)
Anti-PMEL Reference Antibody (Novartis patent anti-PMEL17)
Anti-PROM1 / CD133 Reference Antibody (Forerunner patent anti-Prominin-1)
Anti-RHD / CD240d Reference Antibody (roledumab)
Anti-RTN4 / NOGO Reference Antibody (NG-101)
Anti-Siglec-2 / CD22 Reference Antibody (epratuzumab)
Anti-Siglec-3 / CD33 Reference Antibody (IMGN779)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (nivolumab)
Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab)
Anti-Siglec-15 / CD33L3 Reference Antibody (NC318)
Anti-RTN4 / NOGO Reference Antibody (atinumab)
Anti-RHD / CD240d Reference Antibody (LFB Anti-RhD)
Anti-PRLR / Prolactin Receptor Reference Antibody (rolinsatamab)
Anti-PMEL Reference Antibody (Genentech anti-PMEL17)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (tislelizumab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (retifanlimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (budigalimab)
Anti-PCSK9 Reference Antibody (recaticimab)
Anti-SLAMF7 / CS1 Reference Antibody (PDL241)
Anti-SIRPA / CD172a Reference Antibody (Hospital for Sick Children patent anti-SIRPA)
Anti-Serum Amyloid P / SAP Reference Antibody (dezamizumab)
Anti-SCFR / c-Kit / CD117 Reference Antibody (LOP628)
Anti-RAMP3 Reference Antibody (Medella patent anti-RAMP-3)
Anti-PTK7 / CCK4 Reference Antibody (cofetuzumab)
Anti-Phosphatidylserine Reference Antibody (bavituximab)
Anti-PDGFRA / CD140a Reference Antibody (olaratumab)
Anti-Siglec-2 / CD22 Reference Antibody (NCI m972)
Anti-Siglec-15 / CD33L3 Reference Antibody (Medimmune patent anti-Siglec-15)
Anti-RSPO3 Reference Antibody (rosmantuzumab)
Anti-RGMC / HFE2 Reference Antibody (DISC-0974)
Anti-PVRIG Reference Antibody (COM701)
Anti-PLAUR / uPAR / CD87 Reference Antibody (ATN-658)
Anti-PDGFRB / CD140b Reference Antibody (rinucumab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (prolgolimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (nofazinlimab)
Anti-PCSK9 Reference Antibody (ralpancizumab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pimivalimab)
Anti-PDGFRB / CD140b Reference Antibody (IMC-2C5)
Anti-PLA2G1B Reference Antibody (Diaccurate patent anti-sPLA2-GIB)
Anti-PTPRC / CD45 Reference Antibody (Novartis patent anti-CD45)
Anti-RGMA Reference Antibody (elezanumab)
Anti-SCN9a / Nav1.7 Reference Antibody (Duke anti-NAv1.7)
Anti-Siglec-15 / CD33L3 Reference Antibody (AB-25E9)
Anti-SLAMF6 / CD352 Reference Antibody (SGN-CD352A)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (finotonlimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab)
Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics patent anti-PDGF-C)
Anti-PGLYRP1 / PGRP-S Reference Antibody (Novo Nordisk patent anti-PGLYRP1)
Anti-PSGL1 / CD162 Reference Antibody (neihulizumab)
Anti-PVRIG Reference Antibody (GSK4381562)
Anti-SCFR / c-Kit / CD117 Reference Antibody (CDX-0158)
Anti-SERPINE1 Reference Antibody (Sanofi patent anti-PAI-1)
Anti-Siglec-8 Reference Antibody (lirentelimab)
Anti-SLAMF7 / CS1 Reference Antibody (elotuzumab)
Anti-PCSK9 Reference Antibody (Schering patent anti-PCSK9)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (cetrelimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (serplulimab)
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (UCB patent anti-PD-1)
Anti-Polyubiquitin Reference Antibody (Genentech patent anti-Polyubiquitin)
Anti-PSCA Reference Antibody (AGS-1C4D4)
Anti-ROBO1 Reference Antibody (Asclepius Technology patent anti-Robo1 CAR)
Anti-RTN4 / NOGO Reference Antibody (ozanezumab)
Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab)
Anti-Siglec-3 / CD33 Reference Antibody (lintuzumAb)
48
49
50
51
52
53
54
55
56
57
Copyright 2019 © ChemicalBook. All rights reserved